期刊
ANNALS OF SURGERY
卷 243, 期 4, 页码 472-478出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/01.sla.0000208430.07050.61
关键词
-
类别
资金
- NCI NIH HHS [1R21 CA 89410-01, R21 CA089410] Funding Source: Medline
Objective: To evaluate the utility of F-18-FDG-PET in predicting response to concomitant chemoradiation in locally-advanced esophageal cancer. Summary Background Data: Approximately 25% of esophageal cancer patients experience a pathologic complete response (pCR) to preoperative chemoradiation therapy. Computed tomography, endoscopy, and endoscopic ultrasound are unable to identify patients experiencing a pCR. Growing evidence supports the use of F-18-FDG-PET in the staging of esophageal cancer in its ability to detect occult metastatic and lymph nodal disease. The identification of patients with a pCR to chemoradiation could potentially spare those patients the morbidity associated with a resection. Methods: Eligibility criteria included T3-T4N0M0 or T1-T4N1 MO esophageal cancer. Patients underwent an initial F-18-FDG-PET before treatment and then repeated 4 to 6 weeks after chemoradiation, prior to the esophagectomy. Chemoradiation consisted of: cisplatinum, 5-fluorouracil, and radiation to a median dose of 50.4 Gy. Pathologic response was determined from a systematic review of the esophagectomy specimens. Results: Sixty-four patients have completed therapy to date. Response was as follows: pCR 27%, pathologic residual microscopic (pCR(micro)) 14.5%, partial response 19%, and stable or progressive disease 39.5%. A pretreatment standardized uptake value (SUVmax1 hour) >= 15 was associated with an observed 77.8% significant response (pCR + pCR(micro)) compared with 24.2% for patients with a pretreatment SUVmax1 hour < 15 (P = 0.005). Significant response was observed in 71.4% of patients with a decrease in SUVmax1 hour >= 10 compared with 33.3% when the SUVmax1 hour decreased < 10 (P = 0.004). Conclusions: Pretreatment and posttreatment F-18-FDG-PET can be useful for predicting significant response to chemoradiation in esophageal cancer. These data should be considered in evaluation of patients for esophagectomy after chemoradiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据